kabutan

Medrx, First Half Net Income Loss Widens, Apr-Jun Net Income Turns to Loss

Fri Aug 8, 2025 3:30 pm JST Earnings

4586 Medrx Co.,Ltd. 【J-GAAP】

Earnings Report

Medrx Co.,Ltd. <4586> [TSE Growth] announced its financial results after the market closed on August 8th (15:30). The consolidated net loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) expanded to a loss of 629 million yen (compared to a loss of 61 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the July to December period (second half) is expected to nearly flat at loss of 721 million yen (compared to a loss of 745 million yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the consolidated net income/loss turned to a loss of 200 million yen (compared to a profit of 67 million yen in the same period last year). The operating profit/loss margin drastically worsened from 17.7% in the same period last year to -1187.5%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 6 -478 -480 -481 -15.0 ー Aug 10, 2023 J-GAAP
Jan - Jun, 2024 231 -135 -84 -61 -1.5 ー Aug 9, 2024 J-GAAP
Jan - Jun, 2025 18 -609 -623 -629 -12.8 ー Aug 8, 2025 J-GAAP
YoY -92.2% -351.1% -641.7% -931.1% -749.0%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
Jan - Jun, 2025 Results 18 -609 -623 -629 -12.8 0 Aug 8, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 26 -658 -671 -745 -17.2 0 Feb 14, 2025 J-GAAP
Jul - Dec, 2025 Guidance 104 -726 -712 -721 -12.1 0 Aug 8, 2025 J-GAAP
YoY +300.0% -10.3% -6.1% +3.2% +29.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 29 -933 -930 -932 -26.8 0 Feb 9, 2024 J-GAAP
Dec, 2024 257 -793 -755 -806 -18.6 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance 122 -1,335 -1,335 -1,350 -22.7 0 Feb 14, 2025 J-GAAP
YoY -52.5% -68.3% -76.8% -67.5% -22.5%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 231 41 43 67 1.7 17.7 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 24 -244 -259 -259 -6.2 -1,016.7 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 2 -414 -412 -486 -11.2 -20,700.0 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 2 -419 -422 -429 -9.0 -20,950.0 May 9, 2025 J-GAAP
Apr - Jun, 2025 16 -190 -201 -200 -4.1 -1,187.5 Aug 8, 2025 J-GAAP
YoY -93.1% － － － －

Related Articles